Story
J&J Talc Lawsuits Face Potential Dismissal After Judge Questions Cancer Evidence

A U.S. federal judge has questioned the validity of claims in approximately 69,000 lawsuits alleging that Johnson & Johnson's talc products caused ovarian cancer, a move that could jeopardize the massive litigation against the healthcare giant. The judge stated that plaintiffs must provide more specific evidence linking the products to their cancer or face potential dismissal of their cases.
Judge Cites Expert Testimony
In an opinion issued Wednesday, U.S. Magistrate Judge Rukhsanah Singh in Trenton, New Jersey, highlighted recent testimony from two expert witnesses for the plaintiffs, Judith Wolf and Daniel Clarke-Pearson. According to the judge, the experts testified in May that they could not definitively rule out other potential causes for the plaintiffs' ovarian cancer.
Judge Singh wrote that this testimony raises doubts about whether any plaintiff can present court-admissible evidence proving "that talcum powder use specifically caused her ovarian cancer." The judge questioned how plaintiffs could meet their legal burden of proof given this uncertainty, writing, "If such uncertainty is indeed reality, then how can any plaintiff here meet her burden on the merits of her claim?"
Implications for Litigation
The ruling is a significant development in the consolidated federal litigation against J&J. The expert testimony was part of preparations for a series of "bellwether" trials, which are used as test cases to help guide settlement negotiations for the thousands of remaining lawsuits.
AdWhile Judge Singh noted the issue would not lead to an "instant dismissal" of the cases, she has ordered the plaintiffs to respond by November 19. They must explain why their lawsuits should not be dismissed for failing to provide an admissible expert opinion on the specific cause of their cancer.
Context and Company Position
Johnson & Johnson has consistently denied allegations that its talc products, including its iconic Baby Powder, are carcinogenic. The company has maintained that decades of scientific studies show the products are safe and do not contain asbestos.
A lead attorney for the plaintiffs and a spokesperson for Johnson & Johnson did not immediately respond to a request for comment on the ruling, according to Reuters. The decision marks a critical juncture in one of the largest mass tort litigations in U.S. history.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.